Roland Rott - Feb 1, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Ultrasound
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 05:01 PM
Previous filing
Jan 5, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +2.23K +10.76% $0.00 23K Feb 1, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +19.6K 19.6K Feb 1, 2023 Common Stock, par value $0.01 per share 19.6K $70.01 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 2,231 newly awarded restricted stock units, 20,488 previously reported restricted stock units, and 245 shares of common stock.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.